+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Humanized Mouse Model Market 2025-2029

  • PDF Icon

    Report

  • 214 Pages
  • June 2025
  • Region: Global
  • TechNavio
  • ID: 5031202
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The humanized mouse model market is forecasted to grow by USD 61.6 million during 2024-2029, accelerating at a CAGR of 6.7% during the forecast period. The report on the humanized mouse model market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing adoption of personalized medicine, innovative applications of humanized mouse models, and advancements in genetic engineering technologies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The humanized mouse model market is segmented as below:

By Product Type

  • GHMM
  • Cell-based humanized mouse model

By End-user

  • Pharmaceutical and biotechnology companies
  • CROs
  • Academic and research institutions

By Application

  • Oncology
  • Immunology and infectious diseases
  • Neuroscience
  • Toxicology and hematopoiesis

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the strategic alliances of companies as one of the prime reasons driving the humanized mouse model market growth during the next few years. Also, increasing production of mabs and emergence of whole animal imaging will lead to sizable demand in the market.

The report on the humanized mouse model market covers the following areas:

  • Humanized Mouse Model Market sizing
  • Humanized Mouse Model Market forecast
  • Humanized Mouse Model Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading humanized mouse model market vendors that include Altogen labs, Aragen Life Sciences Pvt. Ltd., Biocytogen Pharmaceuticals Co. Ltd., BioSafety Research Center Inc., Champions Oncology Inc., Charles River Laboratories International Inc., Creative Biolabs, Cyagen Biosciences, Gempharmatech Co. Ltd., GenOway, HBM Holdings Ltd., Hera Biolabs Inc., ingenious targeting laboratory, Inotiv Inc., JANVIER LABS, JSR Corp., Oncodesign Precision Medicine, Ozgene Pty Ltd., Perkin Elmer Inc., and Pharmatest services. Also, the humanized mouse model market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product Type
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Humanized Mouse Model Market 2019 - 2023
Historic Market Size - Data Table on Global Humanized Mouse Model Market 2019 - 2023 ($ million)
5.2 Product Type segment analysis 2019 - 2023
Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
5.3 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.4 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Humanized Mouse Model Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product Type
8.1 Market segments
Chart on Product Type - Market share 2024-2029 (%)
Data Table on Product Type - Market share 2024-2029 (%)
8.2 Comparison by Product Type
Chart on Comparison by Product Type
Data Table on Comparison by Product Type
8.3 GHMM - Market size and forecast 2024-2029
Chart on GHMM - Market size and forecast 2024-2029 ($ million)
Data Table on GHMM - Market size and forecast 2024-2029 ($ million)
Chart on GHMM - Year-over-year growth 2024-2029 (%)
Data Table on GHMM - Year-over-year growth 2024-2029 (%)
8.4 Cell-based humanized mouse model - Market size and forecast 2024-2029
Chart on Cell-based humanized mouse model - Market size and forecast 2024-2029 ($ million)
Data Table on Cell-based humanized mouse model - Market size and forecast 2024-2029 ($ million)
Chart on Cell-based humanized mouse model - Year-over-year growth 2024-2029 (%)
Data Table on Cell-based humanized mouse model - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Product Type
Market opportunity by Product Type ($ million)
Data Table on Market opportunity by Product Type ($ million)
9 Market Segmentation by End-user
9.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
9.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
9.3 Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029
Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
9.4 CROs - Market size and forecast 2024-2029
Chart on CROs - Market size and forecast 2024-2029 ($ million)
Data Table on CROs - Market size and forecast 2024-2029 ($ million)
Chart on CROs - Year-over-year growth 2024-2029 (%)
Data Table on CROs - Year-over-year growth 2024-2029 (%)
9.5 Academic and research institutions - Market size and forecast 2024-2029
Chart on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
Data Table on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
Chart on Academic and research institutions - Year-over-year growth 2024-2029 (%)
Data Table on Academic and research institutions - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
10 Market Segmentation by Application
10.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
10.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
10.3 Oncology - Market size and forecast 2024-2029
Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Chart on Oncology - Year-over-year growth 2024-2029 (%)
Data Table on Oncology - Year-over-year growth 2024-2029 (%)
10.4 Immunology and infectious diseases - Market size and forecast 2024-2029
Chart on Immunology and infectious diseases - Market size and forecast 2024-2029 ($ million)
Data Table on Immunology and infectious diseases - Market size and forecast 2024-2029 ($ million)
Chart on Immunology and infectious diseases - Year-over-year growth 2024-2029 (%)
Data Table on Immunology and infectious diseases - Year-over-year growth 2024-2029 (%)
10.5 Neuroscience - Market size and forecast 2024-2029
Chart on Neuroscience - Market size and forecast 2024-2029 ($ million)
Data Table on Neuroscience - Market size and forecast 2024-2029 ($ million)
Chart on Neuroscience - Year-over-year growth 2024-2029 (%)
Data Table on Neuroscience - Year-over-year growth 2024-2029 (%)
10.6 Toxicology and hematopoiesis - Market size and forecast 2024-2029
Chart on Toxicology and hematopoiesis - Market size and forecast 2024-2029 ($ million)
Data Table on Toxicology and hematopoiesis - Market size and forecast 2024-2029 ($ million)
Chart on Toxicology and hematopoiesis - Year-over-year growth 2024-2029 (%)
Data Table on Toxicology and hematopoiesis - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.11 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.12 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.13 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.14 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 Altogen labs
Altogen labs - Overview
Altogen labs - Product / Service
Altogen labs - Key offerings
SWOT
15.5 Aragen Life Sciences Pvt. Ltd.
Aragen Life Sciences Pvt. Ltd. - Overview
Aragen Life Sciences Pvt. Ltd. - Product / Service
Aragen Life Sciences Pvt. Ltd. - Key offerings
SWOT
15.6 Biocytogen Pharmaceuticals Co. Ltd.
Biocytogen Pharmaceuticals Co. Ltd. - Overview
Biocytogen Pharmaceuticals Co. Ltd. - Product / Service
Biocytogen Pharmaceuticals Co. Ltd. - Key offerings
SWOT
15.7 BioSafety Research Center Inc.
BioSafety Research Center Inc. - Overview
BioSafety Research Center Inc. - Product / Service
BioSafety Research Center Inc. - Key offerings
SWOT
15.8 Champions Oncology Inc.
Champions Oncology Inc. - Overview
Champions Oncology Inc. - Product / Service
Champions Oncology Inc. - Key offerings
SWOT
15.9 Charles River Laboratories International Inc.
Charles River Laboratories International Inc. - Overview
Charles River Laboratories International Inc. - Business segments
Charles River Laboratories International Inc. - Key offerings
Charles River Laboratories International Inc. - Segment focus
SWOT
15.10 Creative Biolabs
Creative Biolabs - Overview
Creative Biolabs - Product / Service
Creative Biolabs - Key offerings
SWOT
15.11 Cyagen Biosciences
Cyagen Biosciences - Overview
Cyagen Biosciences - Product / Service
Cyagen Biosciences - Key offerings
SWOT
15.12 Gempharmatech Co. Ltd.
Gempharmatech Co. Ltd. - Overview
Gempharmatech Co. Ltd. - Product / Service
Gempharmatech Co. Ltd. - Key offerings
SWOT
15.13 GenOway
GenOway - Overview
GenOway - Product / Service
GenOway - Key offerings
SWOT
15.14 HBM Holdings Ltd.
HBM Holdings Ltd. - Overview
HBM Holdings Ltd. - Product / Service
HBM Holdings Ltd. - Key offerings
SWOT
15.15 Hera Biolabs Inc.
Hera Biolabs Inc. - Overview
Hera Biolabs Inc. - Product / Service
Hera Biolabs Inc. - Key offerings
SWOT
15.16 ingenious targeting laboratory
ingenious targeting laboratory - Overview
ingenious targeting laboratory - Product / Service
ingenious targeting laboratory - Key offerings
SWOT
15.17 JSR Corp.
JSR Corp. - Overview
JSR Corp. - Business segments
JSR Corp. - Key offerings
JSR Corp. - Segment focus
SWOT
15.18 Perkin Elmer Inc.
Perkin Elmer Inc. - Overview
Perkin Elmer Inc. - Business segments
Perkin Elmer Inc. - Key offerings
Perkin Elmer Inc. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Market Segmentation by Application
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Humanized Mouse Model Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Product Type - Market share 2024-2029 (%)
Exhibits 39: Data Table on Product Type - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Product Type
Exhibits 41: Data Table on Comparison by Product Type
Exhibits 42: Chart on GHMM - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on GHMM - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on GHMM - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on GHMM - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on Cell-based humanized mouse model - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on Cell-based humanized mouse model - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on Cell-based humanized mouse model - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on Cell-based humanized mouse model - Year-over-year growth 2024-2029 (%)
Exhibits 50: Market opportunity by Product Type ($ million)
Exhibits 51: Data Table on Market opportunity by Product Type ($ million)
Exhibits 52: Chart on End-user - Market share 2024-2029 (%)
Exhibits 53: Data Table on End-user - Market share 2024-2029 (%)
Exhibits 54: Chart on Comparison by End-user
Exhibits 55: Data Table on Comparison by End-user
Exhibits 56: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
Exhibits 57: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
Exhibits 58: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
Exhibits 59: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
Exhibits 60: Chart on CROs - Market size and forecast 2024-2029 ($ million)
Exhibits 61: Data Table on CROs - Market size and forecast 2024-2029 ($ million)
Exhibits 62: Chart on CROs - Year-over-year growth 2024-2029 (%)
Exhibits 63: Data Table on CROs - Year-over-year growth 2024-2029 (%)
Exhibits 64: Chart on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
Exhibits 65: Data Table on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
Exhibits 66: Chart on Academic and research institutions - Year-over-year growth 2024-2029 (%)
Exhibits 67: Data Table on Academic and research institutions - Year-over-year growth 2024-2029 (%)
Exhibits 68: Market opportunity by End-user ($ million)
Exhibits 69: Data Table on Market opportunity by End-user ($ million)
Exhibits 70: Chart on Application - Market share 2024-2029 (%)
Exhibits 71: Data Table on Application - Market share 2024-2029 (%)
Exhibits 72: Chart on Comparison by Application
Exhibits 73: Data Table on Comparison by Application
Exhibits 74: Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits 75: Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits 76: Chart on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits 77: Data Table on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits 78: Chart on Immunology and infectious diseases - Market size and forecast 2024-2029 ($ million)
Exhibits 79: Data Table on Immunology and infectious diseases - Market size and forecast 2024-2029 ($ million)
Exhibits 80: Chart on Immunology and infectious diseases - Year-over-year growth 2024-2029 (%)
Exhibits 81: Data Table on Immunology and infectious diseases - Year-over-year growth 2024-2029 (%)
Exhibits 82: Chart on Neuroscience - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Data Table on Neuroscience - Market size and forecast 2024-2029 ($ million)
Exhibits 84: Chart on Neuroscience - Year-over-year growth 2024-2029 (%)
Exhibits 85: Data Table on Neuroscience - Year-over-year growth 2024-2029 (%)
Exhibits 86: Chart on Toxicology and hematopoiesis - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Data Table on Toxicology and hematopoiesis - Market size and forecast 2024-2029 ($ million)
Exhibits 88: Chart on Toxicology and hematopoiesis - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on Toxicology and hematopoiesis - Year-over-year growth 2024-2029 (%)
Exhibits 90: Market opportunity by Application ($ million)
Exhibits 91: Data Table on Market opportunity by Application ($ million)
Exhibits 92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 93: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 94: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 95: Chart on Geographic comparison
Exhibits 96: Data Table on Geographic comparison
Exhibits 97: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 98: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 100: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 101: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 102: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 103: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 150: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 151: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 153: Market opportunity By Geographical Landscape ($ million)
Exhibits 154: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 155: Impact of drivers and challenges in 2024 and 2029
Exhibits 156: Overview on criticality of inputs and factors of differentiation
Exhibits 157: Overview on factors of disruption
Exhibits 158: Impact of key risks on business
Exhibits 159: Companies covered
Exhibits 160: Company ranking index
Exhibits 161: Matrix on companies position and classification
Exhibits 162: Altogen labs - Overview
Exhibits 163: Altogen labs - Product / Service
Exhibits 164: Altogen labs - Key offerings
Exhibits 165: SWOT
Exhibits 166: Aragen Life Sciences Pvt. Ltd. - Overview
Exhibits 167: Aragen Life Sciences Pvt. Ltd. - Product / Service
Exhibits 168: Aragen Life Sciences Pvt. Ltd. - Key offerings
Exhibits 169: SWOT
Exhibits 170: Biocytogen Pharmaceuticals Co. Ltd. - Overview
Exhibits 171: Biocytogen Pharmaceuticals Co. Ltd. - Product / Service
Exhibits 172: Biocytogen Pharmaceuticals Co. Ltd. - Key offerings
Exhibits 173: SWOT
Exhibits 174: BioSafety Research Center Inc. - Overview
Exhibits 175: BioSafety Research Center Inc. - Product / Service
Exhibits 176: BioSafety Research Center Inc. - Key offerings
Exhibits 177: SWOT
Exhibits 178: Champions Oncology Inc. - Overview
Exhibits 179: Champions Oncology Inc. - Product / Service
Exhibits 180: Champions Oncology Inc. - Key offerings
Exhibits 181: SWOT
Exhibits 182: Charles River Laboratories International Inc. - Overview
Exhibits 183: Charles River Laboratories International Inc. - Business segments
Exhibits 184: Charles River Laboratories International Inc. - Key offerings
Exhibits 185: Charles River Laboratories International Inc. - Segment focus
Exhibits 186: SWOT
Exhibits 187: Creative Biolabs - Overview
Exhibits 188: Creative Biolabs - Product / Service
Exhibits 189: Creative Biolabs - Key offerings
Exhibits 190: SWOT

Executive Summary

The following companies are recognized as the key players in the global humanized mouse model market: Altogen labs, Aragen Life Sciences Pvt. Ltd., Biocytogen Pharmaceuticals Co. Ltd., BioSafety Research Center Inc., Champions Oncology Inc., Charles River Laboratories International Inc., Creative Biolabs, Cyagen Biosciences, Gempharmatech Co. Ltd., GenOway, HBM Holdings Ltd., Hera Biolabs Inc., ingenious targeting laboratory, Inotiv Inc., JANVIER LABS, JSR Corp., Oncodesign Precision Medicine, Ozgene Pty Ltd., Perkin Elmer Inc., and Pharmatest services.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strategic alliances of companies."

According to the report, one of the major drivers for this market is the growing adoption of personalized medicine.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Altogen labs
  • Aragen Life Sciences Pvt. Ltd.
  • Biocytogen Pharmaceuticals Co. Ltd.
  • BioSafety Research Center Inc.
  • Champions Oncology Inc.
  • Charles River Laboratories International Inc.
  • Creative Biolabs
  • Cyagen Biosciences
  • Gempharmatech Co. Ltd.
  • GenOway
  • HBM Holdings Ltd.
  • Hera Biolabs Inc.
  • ingenious targeting laboratory
  • Inotiv Inc.
  • JANVIER LABS
  • JSR Corp.
  • Oncodesign Precision Medicine
  • Ozgene Pty Ltd.
  • Perkin Elmer Inc.
  • Pharmatest services